Outlook Therapeutics
OTLK
OTLK
63 hedge funds and large institutions have $8.64M invested in Outlook Therapeutics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
24
Reduced
14
Closed
10
Calls
$74K
Puts
$32K
Net Calls
+$42K
Net Calls Change
-$3.56M
Top Buyers
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$1.89M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$1.05M |
| 3 |
SPIA
Steward Partners Investment Advisory
New York
|
+$447K |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
+$265K |
| 5 |
BlackRock
New York
|
+$182K |
Top Sellers
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$286K |
| 2 |
Renaissance Technologies
New York
|
-$246K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$234K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$210K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$190K |
